Much of the European Union (EU) budget follows Annual Growth Survey (AGS) priorities, but member states' budgets do not necessarily follow the country-specific recommendations. Doing so and addressing wider concerns about the AGS could help the EU and member states identify the benefits of the AGS.
Nov 21, 2017 E!Sharp
Reversing the Schengen agreement would come at a high economic cost, while undoing many of the positive social and political developments of the past decade.
Oct 13, 2016 E!Sharp
Many common infections are becoming resistant to the antimicrobial medicines used to treat them, resulting in longer illnesses and more deaths. The fact that world leaders are using the UN as a forum for discussions about AMR is a promising move toward developing a coordinated global plan.
Sep 19, 2016 The RAND Blog
The U.S. and the EU are committed to tackling antimicrobial resistance. Their efforts share objectives around key areas for improvement, such as the stewardship of existing antimicrobials, surveillance of their use, and development of new antimicrobials.
Aug 19, 2016 The Health Care Blog
Brazilian scientists detected drug-resistant bacteria growing off some of Rio de Janeiro's beaches, close to where it will host sailing and wind-surfing events, and in the lagoon where the rowing and canoeing events will take place.
Jul 29, 2016 Medical Xpress
In addition to being a public health problem, antimicrobial resistance is also a major economic concern. It crosses sectoral boundaries, because resistant bugs can pass between animals and humans, and through food, agriculture, and the environment.
May 20, 2016 Cultures Magazine
The O'Neill Review aims to increase global knowledge of antimicrobial resistance (AMR) and generate international consensus about the nature of the problem and the necessary steps to tackle it. A RAND Europe analysis of the potential economic costs of AMR contributed to the Review.
May 19, 2016 The RAND Blog
Higher levels of social spending are strongly associated with better health outcomes in many countries, with this link strengthening over time. The association also holds when looking at regional differences within the United States, where spending varies state-by-state.
May 11, 2016 The RAND Blog
Corruption costs Europe up to €990 billion in GDP annually, according to a new study. That's more than eight times previous estimates.
Mar 22, 2016 E!Sharp
If left unaddressed, the threat posed by antimicrobial resistance and the rise of 'superbugs' could devastate the world economy and pose a deadly threat to humanity.
Aug 7, 2015 LifeZette
The threat of drug resistance can be tackled with the right set of actions, including the development of new antimicrobial drugs and alternative therapies to disrupt the rise in resistance. German Chancellor Merkel has emphasized the importance of a joint global action plan for addressing this growing problem.
Jun 8, 2015 The RAND Blog
The increase in the number of bacterial and viral infections that are resistant to antimicrobial drugs poses a growing global health threat.
Feb 20, 2015 The RAND Blog
Despite public awareness campaigns in the United States and Europe, many people persist in the mistaken belief that antibacterial drugs — like amoxicillin and azithromycin — are the best treatment for flu. And many doctors simply surrender when patients demand them, ignoring the scientific and medical truth: when treating the flu, antibacterial drugs just don't work.
Oct 28, 2013 Reuters, The Great Debate blog
Antimicrobial drugs are no longer working as they once did. The bugs that they are supposed to attack are becoming increasingly resistant. Microbes follow the same rules of evolution as we do. Through reproduction and natural selection the fittest survive.
Sep 18, 2013 The RAND Blog